Despite its potential, bioproduction faces several challenges. One of the primary issues is the scalability of biological systems to produce nanomaterials in large quantities. Another challenge is the consistency and reproducibility of the nanomaterials produced. Additionally, there are regulatory hurdles to overcome, especially for biomedical applications, where the safety and efficacy of bioproduced nanomaterials must be thoroughly validated.
